Source: Richard Craver, WINSTON-SALEM JOURNAL, 12/5/18


22nd Century Group Inc. has entered the Food and Drug Administration regulatory gauntlet for its very-low nicotine traditional cigarettes, the company said Wednesday. The manufacturer submitted a premarket tobacco application for its “Brand A” product, which has been the subject of more than 50 global studies. Some of those studies have been funded all or in part by the FDA and National Institutes of Health. The products initially would go by the brand VLNTM. The FDA has authority over product names.

For more of this story, click here.